Evidence map›Paper›PMID 35262761›Full record

ArticleSocial psychiatry and psychiatric epidemiology2022

Perceived helpfulness of treatment for social anxiety disorder: findings from the WHO World Mental Health Surveys.

Ronny Bruffaerts, Meredith G Harris, Alan E Kazdin, Daniel V Vigo, Nancy A Sampson, Wai Tat Chiu, Ali Al-Hamzawi, Jordi Alonso, Yasmin A Altwaijri, Laura Andrade and 22 more

Open access · bronzeAbstract read
In one paragraph

Article in Social psychiatry and psychiatric epidemiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. A Proton Magnetic Resonance Spectroscopy (International journal of molecular sciences · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 20 institutions in 24 countries.

Ronny BruffaertsUniversitair Psychiatrisch Centrum-Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium.
Meredith G HarrisSchool of Public Health, The University of Queensland, Queensland, Herston, Australia.
Alan E KazdinDepartment of Psychology, Yale University, New Haven, CT, USA.
Daniel V VigoDepartment of Psychiatry, University of British Columbia, Vancouver, BC, Canada.
Nancy A SampsonDepartment of Health Care Policy, Harvard Medical School, 180 Longwood Avenue, Boston, MA, 02115, USA.
Wai Tat ChiuDepartment of Health Care Policy, Harvard Medical School, 180 Longwood Avenue, Boston, MA, 02115, USA.
Ali Al-HamzawiCollege of Medicine, Al-Qadisiyah University, Diwaniyah Governorate, Iraq.
Jordi AlonsoHealth Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain.
Yasmin A AltwaijriEpidemiology Section, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Laura AndradeNúcleo de Epidemiologia Psiquiátrica-LIM 23, Instituto de Psiquiatria Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Corina BenjetDepartment of Epidemiologic and Psychosocial Research, National Institute of Psychiatry Ramón de la Fuente Muñiz, Mexico City, Mexico.
Giovanni de GirolamoIRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
Silvia FlorescuNational School of Public Health, Management and Development, Bucharest, Romania.
Josep Maria HaroParc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Sant Boi de Llobregat, Barcelona, Spain.
Chi-Yi HuShenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Shenzhen, China.
Aimee KaramInstitute for Development, Research, Advocacy and Applied Care (IDRAAC), Beirut, Lebanon.
Elie G KaramInstitute for Development, Research, Advocacy and Applied Care (IDRAAC), Beirut, Lebanon.
Viviane Kovess-MasfetyEcole des Hautes Etudes en Santé Publique (EHESP), EA 4057, Paris Descartes University, Paris, France.
Sing LeeDepartment of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong.
John J McGrathQueensland Centre for Mental Health Research, The Park Centre for Mental Health, Queensland, Wacol, Australia.
Fernando Navarro-MateuUDIF-SM, Servicio Murciano de Salud, IMIB-Arrixaca, CIBERESP-Murcia, Región de Murcia, Spain.
Daisuke NishiDepartment of Mental Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Siobhan O'NeillSchool of Psychology, Ulster University, Londonderry, UK.
José Posada-VillaFaculty of Social Sciences, Colegio Mayor de Cundinamarca University, Bogota, Colombia.
Kate M ScottDepartment of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand.
Margreet Ten HaveTrimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Utrecht, Netherlands.
Yolanda TorresCenter for Excellence on Research in Mental Health, CES University, Medellin, Colombia.
Bogdan WojtyniakDepartment of Population Health Monitoring and Analysis, National Institute of Public Health-National Institute of Hygiene, Warsaw, Poland.
Miguel XavierLisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), NOVA Medical School-Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal.
Zahari ZarkovDepartment of Mental Health, National Center of Public Health and Analyses, Sofia, Bulgaria.
Ronald C KesslerDepartment of Health Care Policy, Harvard Medical School, 180 Longwood Avenue, Boston, MA, 02115, USA. kessler@hcp.med.harvard.edu.ORCID http://orcid.org/0000-0003-4831-2305
WHO World Mental Health Survey Collaborators
Harvard University · USThe University of Queensland · AUUniversity of Balamand · LBCentro San Giovanni di Dio Fatebenefratelli · ITÉcole des Hautes Études en Santé Publique · FRInstituto Nacional de Psiquiatría Ramón de la Fuente Muñiz · MXKU Leuven · BENarodowy Instytut Zdrowia Publicznego PZH – Państwowy Instytut Badawczy · PLServicio Murciano de Salud · ESShenzhen KangNing Hospital · CNTrimbos Institute · NLUniversidad Colegio Mayor de Cundinamarca · COUniversitat Pompeu Fabra · ESUniversity of Al-Qadisiyah · IQChinese University of Hong Kong · HKHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BRKing Faisal Specialist Hospital & Research Centre · SAKing Saud University · SANational School of Public Health, Management and Professional Development · ROUniversidad CES · CO

Funding

EPIDEMIOLOGY-- NATIONAL COMORBIDITY SURVEY REPLICATIONU01MH060220 · NIMH · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI KESSLER, RONALD C · 1999 to 2010
$18.7M
Risk Factors for Psychopathology in the WHO WMH SurveysR01MH070884 · NIMH · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI KESSLER, RONALD C · 2005 to 2009
$6.0M
Social Role Disability and Mental-Physical Co-MorbidityR01MH069864 · NIMH · KAISER FOUNDATION HEALTH PLAN OF WASHINGTON · PI VON KORFF, MICHAEL R · 2004 to 2007
$2.2M
CROSS-NATIONAL STUDIES OF DRUG INVOLVEMENT: WMH2000R01DA016558 · NIDA · MICHIGAN STATE UNIVERSITY · PI ANTHONY, JAMES CHRISTOPHER · 2003 to 2008
$1.7M
World Mental Health Consortium Annual Meeting 2003-07R13MH066849 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HEERINGA, STEVEN G · 2003 to 2007
$735k
Lebanon-Epidemiology: The NCS Replication StudyR03TW006481 · FIC · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI KESSLER, RONALD C · 2004 to 2006
$142k
FIC NIH HHS R03 TW006481Fundação de Amparo à Pesquisa do Estado de São Paulo 03/00204-3NIDA NIH HHS R01 DA016558NIMH NIH HHS R01 MH069864NIMH NIH HHS R01 MH070884NIMH NIH HHS R13 MH066849NIMH NIH HHS U01 MH060220NIMH NIH HHS U01-MH60220
6 · The paper itself

Abstract

purposeTo investigate the prevalence and predictors of perceived helpfulness of treatment in persons with a history of DSM-IV social anxiety disorder (SAD), using a worldwide population-based sample.

methodsThe World Health Organization World Mental Health Surveys is a coordinated series of community epidemiological surveys of non-institutionalized adults; 27 surveys in 24 countries (16 in high-income; 11 in low/middle-income countries; N = 117,856) included people with a lifetime history of treated SAD.

resultsIn respondents with lifetime SAD, approximately one in five ever obtained treatment. Among these (n = 1322), cumulative probability of receiving treatment they regarded as helpful after seeing up to seven professionals was 92.2%. However, only 30.2% persisted this long, resulting in 65.1% ever receiving treatment perceived as helpful. Perceiving treatment as helpful was more common in female respondents, those currently married, more highly educated, and treated in non-formal health-care settings. Persistence in seeking treatment for SAD was higher among those with shorter delays in seeking treatment, in those receiving medication from a mental health specialist, and those with more than two lifetime anxiety disorders.

conclusionsThe vast majority of individuals with SAD do not receive any treatment. Among those who do, the probability that people treated for SAD obtain treatment they consider helpful increases considerably if they persisted in help-seeking after earlier unhelpful treatments.

Indexed as

Phobia, SocialAdultAnxiety DisordersFemaleHealth SurveysHumansSurveys and QuestionnairesWorld Health OrganizationPerceived helpfulnessSocial anxiety disorderTreatment

Identifiers

PMID35262761
PMCPMC9458773
OpenAlexW4220673691

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.